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Mechanical cues induce a variety of downstream effects on cells, including
the regulation of stem cell behavior. Cell fate is typically characterized on
biomaterial substrates where mechanical and chemical properties can be
precisely tuned; however, most of these substrates do not recapitulate the
biological complexity of the extracellular matrix (ECM). Here, hydrogels are
engineered for mechanobiological studies using two major components of the
ECM: hyaluronic acid (HA) and fibronectin (FN). Rather than typical surface
chemisorption of FN to substrates, the system contains full-length FN
covalently crosslinked to HA throughout the hydrogel. The control over the
mechanical properties of the hydrogel independent of the concentration of FN
and the ability to culture viable cells either on top or encapsulated within the
hydrogels are shown. Interestingly, human mesenchymal stem cells (MSCs)
experience an increase in nuclear translocation of the yes-associated protein
(YAP) to the nucleus when cultured on (2D) substrates with increasing
amounts of FN while maintaining constant hydrogel stiffness. However, this
FN dependence on nuclear YAP translocation is not observed for MSCs
encapsulated in (3D) hydrogels. This work develops complex hydrogels that
recapitulate features of the ECM for the control of stem cells in both 2D and
3D environments.
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1. Introduction
Cells respond to a variety of biophysical and
biochemical signals within their microen-
vironment, represented by their extracellu-
lar matrix (ECM) when they reside within
tissues.[1–4] This may include features such
as adhesion to the ECM and the mechani-
cal properties of the surrounding matrix.[5,6]
It is now widely understood that cells sense
the mechanics of their environment, which
has implications in cell signaling and result-
ing behavior, including control over stem
cell differentiation.[3,7] A range of hydrogels
have been designed to culture cells atop
(2D) or encapsulated within (3D) to probe
questions related to mechanobiology. These
systems have been intentionally simple to
decouple the complexity of the microenvi-
ronment; however, there is interest in ele-
vating the complexity to better mimic the
synergistic influence of multiple ECM com-
ponents into our understanding of cellular
mechanosensing.
The ECM comprises a range of biochemical components, from
proteins to polysaccharides. Common in many tissues (e.g., car-
tilage) is the polysaccharide hyaluronic acid (HA), a non-sulfated
glycosaminoglycan. HA is an important element of the ECM and
the structural and biological properties of HA have been impli-
cated in cellular signaling, wound repair, tissue morphogene-
sis, and matrix organization.[8,9] That is why HA has been ex-
tensively used in regenerative medicine.[10] Cells interact with
HA through specific cell-surface receptors, CD44 and the re-
ceptor for hyaluronan-mediated motility (RHAMM).[11,12] For ex-
ample, CD44 has an important role in mesenchymal stem cell
(MSC) migration[13] and homing.[14,15] HA hydrogels have also
been used for in vitro culture and differentiation of embryonic
stem cells due to the role of HA in embryogenesis.[16] Further-
more, HA is a major component of cartilage and HA hydrogels
have been extensively used to promote chondrogenesis.[17,18]
Recently, HA has become an important building block for the
fabrication of new biomaterials used in cell culture and tissue
engineering applications.[19] HA can be modified in numerous
ways to alter the properties of resulting biomaterials, including
their physicochemical features and biological activities. In this
sense, HA can be crosslinked into a hydrogel to form a sta-
ble scaffold through reaction of various chemical groups such
as with aldehydes,[20] divinyl sulfones,[21] or norbornenes.[22]
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Figure 1. Fabrication of full-length FN–HA hydrogels. a) Chemical structure of NorHA and b) NorHA 1H NMR spectra. c) NorHA reaction with thiols
and d) schematic of the formation of hydrogels through the reaction of full-length FN (with exposed thiols) and additional dithiol crosslinker with NorHA.
e) Representative image of a FN–HA hydrogel (scale bar: 6 mm).
Norbornenes react through radically induced thiol–norbornene
click reactions, which are considered to be highly specific
due to the high reactivity of thiols to norbornenes and the
low norbornene–norbornene reactivity.[23] Plus, thiol-ene pho-
tocrosslinking has been useful to encapsulate molecules and cells
while maintaining their bioactivity.[24,25]
Fibronectin (FN) is an abundant glycoprotein that is also found
in the ECM, which is classically studied as a cell adhesion protein
due to its Arg-Gly-Asp (RGD) and Pro-His-Ser-Arg-Asp (PHSRN)
motifs.[26–28] FN or its peptides have been critically used to func-
tionalize materials in mechanotransduction and cell differenti-
ation studies. FN is commonly adsorbed onto different surfaces
such as polyacrylamide and poly(ethylene glycol) (PEG).[29–32] De-
pending on the surface properties, FN adsorption leads to dif-
ferent protein conformations, which can enhance adhesion[33]
or change FN conformation to reveal cryptic sites,[34] such as
the heparin-binding site that has been shown to promiscuously
bind growth factors.[35–38] Apart from its RGD motif and affinity
to several growth factors, FN can bind several other molecules
such as other FN molecules (which support fibrillogenesis),[39,40]
collagen,[41] fibrin, or proteoglycans (e.g., syndecans).[42] More-
over, FN also contains non-RGD-binding integrin motifs.[43] Al-
together, this shows the biological importance of FN and its ver-
satility for use in biomedical applications.
To introduce some complexity of the ECM, we fabricated hy-
drogels from both HA and FN. Specifically, we demonstrate that
full-length FN can be covalently crosslinked into an HA hydrogel
using thiol-ene photocrosslinking to engineer FN–HA hydrogels
with controlled mechanical properties. We show that key prop-
erties, such as the accessibility of the adhesion motif, of the FN
molecule are maintained after incorporation into hydrogels. This
work introduces a new family of hydrogels that recapitulate prop-
erties of the ECM by incorporating full proteins, without small
peptides, or other synthetic components,[44,45] as a platform for
2D and 3D mechanobiological studies.
2. Results and Discussion
2.1. FN–HA Hydrogels via Thiol-Ene Reaction
We used thiol-ene chemistry to fabricate a hydrogel that incor-
porates components of the ECM.[22] We first modified HA with
functional groups to permit crosslinking into hydrogels. Specifi-
cally, HA was modified with norbornene groups following previ-
ous protocols to form norbornene-modified HA (NorHA) (Fig-
ure 1a).[4,22] The synthesized NorHA consisted of ≈20% of its
repeating units functionalized with norbornene groups, as an-
alyzed by nuclear magnetic resonance (1H NMR) (Figure 1b).
Peaks at 6.3–6.2 correspond to vinyl protons, directly attached to
the C=C double bond of the norbornene ring, peaks at 3.0–2.8
and at 1.8–1.0 correspond to the bridge and ring protons.[22,46]
Norbornenes react with thiolated compounds via light-
mediated thiol-ene addition reactions in the presence of a pho-
toinitiator, such as I2959 and UV light (Figure 1c). This strat-
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egy allows control over hydrogel mechanics, which is controlled
by tuning crosslinking density.[22] To form hydrogels that also
include the ECM component FN, we leveraged the cysteine
residues (that carry a thiol group in the side-chain) naturally
present on FN, which can be exposed via protein chemical un-
folding (Figure 1d).[22] Chemical unfolding was achieved using
tris(2-carboxyethyl)phosphine hydrochloride (TCEP), which has
been previously used to expose thiol groups to PEGylate FN and
other proteins such as fibrinogen.[44,45]
FN has been previously incorporated into HA hydrogels us-
ing PEG functionalized with N-hydroxysuccinimide ester as a
crosslinker agent that targets the free amino groups on FN.[47]
This approach increases the probability of blocking key FN bind-
ing sites since amino groups are randomly distributed through-
out the molecule. In our case, we linked FN directly to the HA
backbone by exposing thiol groups that are located at the ends of
the FN molecule. This results in a targeted protein crosslinking
approach and, we have previously shown that this type of mod-
ification (using TCEP) does not affect critical FN binding sites
including cell adhesion and growth factor binding domains.[44]
Further, we also used two different thiolated crosslink-
ers: either dithiothreitol (DTT) or a protease-degradable pep-
tide (GCRDVPMSMRGGDRCG). This approach has been used
before to fabricate nondegradable or degradable HA hydro-
gels, respectively.[4,48] Cell-mediated degradation (e.g., using a
protease-sensitive peptide as a crosslinker) allows cells to spread
and migrate within the hydrogel, and previous HA hydrogel sys-
tems that incorporate FN lack this critical feature for 3D cell
culture.[4,47,49,50] Thus, our design resulted in the fabrication of
optically transparent (Figure 1e) FN–HA hydrogels with control-
lable crosslinking density and degradation.
2.2. FN Incorporation into HA Hydrogels
To assess the incorporation of FN within the hydrogels, we fab-
ricated HA hydrogels using either chemically unfolded FN (i.e.,
using TCEP to expose thiol groups) or native FN (i.e., without ex-
posing thiol groups). Hydrogels are labeled HA XFN, where X is
the concentration of FN incorporated into the hydrogel in micro-
grams per milliliter. After forming the hydrogels, we performed
a series of washes to remove any uncrosslinked protein from the
hydrogel before visualizing remaining FN with immunostaining
(Figure 2a–d). FN was detected in all FN–HA hydrogels, both
when nondegradable using DTT as a crosslinker (Figure 2a) or
degradable using a protease-degradable peptide (Figure 2b), con-
firming the incorporation of FN into HA hydrogels. Moreover,
FN was detected homogeneously when imaging both from the
hydrogel surface or cross section.
As expected, FN was not detected in the controls of HA-only
hydrogels where FN was not included during formation (Fig-
ure 2c). Additionally, FN was not visualized in the hydrogels fab-
ricated with only native FN (Figure 2d), meaning that FN diffused
from hydrogels without covalent crosslinking. This emphasizes
the importance of the crosslinking strategy outlined in Figure 1
to retain the FN within the hydrogel.
To further explore the efficiency of crosslinking using thiol-ene
chemistry, we performed a FN release study where we tracked the
diffusion of FN from the hydrogels. We fluorescently tagged FN
that was incorporated into NorHA hydrogels with either thiols
exposed (to covalently bind the protein) or in its native form (to
physically trap the protein). As seen in Figure 2e, when FN is not
crosslinked (i.e., just physically trapped into the HA network),
there is constant release of FN for 7 days (i.e., FN is diffusing
from the hydrogel as it is not crosslinked), whereas when FN is
crosslinked to NorHA, there is a first burst release (although 30%
lower than the burst release for the uncrosslinked counterpart)
and afterwards FN release drops continuously, until being unde-
tectable after 4 days, demonstrating the stability of the covalent
binding of FN into the NorHA network.
2.3. Mechanical Properties of FN–HA Hydrogels Can Be
Controlled
The mechanical properties of the hydrogels were tested in com-
pression using dynamic mechanical analysis (DMA). As shown
in Figure 2f, the elastic modulus increased monotonically with in-
creasing crosslinker concentration up to an XDTT (ratio between
thiol and norbornene groups) of 1. When surpassing an equal
number of norbornene groups and thiol groups, the modulus
starts to decrease. The excess in thiol groups means that not all
crosslinkers are fully reacted and form effective crosslinks as has
been previously discussed on similar hydrogel systems that use
thiol-ene chemistry.[22,51,52] The range of moduli observed was
from <1 to 15 kPa, for the concentration of NorHA used (2 wt%).
This range could be further tuned by using different NorHA con-
centrations or HA with higher norbornene modifications.[22]
We selected a crosslinker concentration of XDTT equal to 0.6,
which presented an elastic modulus of ≈7 kPa (Figure 2f). This
range was chosen to be able to study early cell adhesion, focal
adhesion (FA) formation, and nuclear YAP translocation.[31] We
also selected this crosslinker density to fabricate FN–HA hydro-
gels that retained enough norbornenes for incorporation of in-
creasing amounts of FN (up to 2000 µg mL−1 compared to tenfold
lower FN incorporation in HA hydrogels by others[47,49]).
Then, the mechanical properties of these hydrogels with in-
creasing amounts of FN were characterized (Figure 2g). Interest-
ingly, all hydrogels had similar average elastic moduli of ≈7 kPa
(no statistically significant differences), independent of the final
concentration of FN used. This implies that although various FN
amounts can be incorporated into hydrogels, the mechanics are
largely driven by the initial crosslinker amount (XDTT). A similar
observation was described recently for synthetic PEG hydrogels
with and without FN.[44] In this case, the concentration of FN did
not alter the elastic modulus measured by nanoindentation. We
expect, however, to see an effect in the viscosity of the hydrogels
with increasing amounts of FN added, as we only tested the bulk
elastic modulus of the hydrogels. This further demonstrates that
we can engineer hydrogels with different amounts of FN incorpo-
rated while maintaining the same mechanical properties, which
is particularly interesting to allow probing of the influence of the
microenvironment on cell behavior.
2.4. MSCs on FN–HA Hydrogels
Human MSCs were seeded on FN–HA hydrogels containing dif-
ferent amounts of FN (Figure 3). MSCs on hydrogels without FN
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Figure 2. FN incorporated into HA hydrogels with controlled mechanical properties. a) Nondegradable (DTT crosslinker) and b) degradable (protease-
degradable peptide crosslinker) HA 50FN hydrogel surface (top) and cross section (bottom). c) HA 0FN and d) HA with native (not unfolded) FN.
Scale bar: 500 µm. e) FN release from either hydrogels with FN crosslinked (blue) or physically trapped (non-crosslinked, orange) (mean ± SD, n = 3,
measured in triplicate); **p < 0.01, ***p < 0.005, ****p < 0.001 via t-test for each time point. f) Elastic modulus of HA 0FN hydrogels using different
crosslinking densities (XDTT is the ratio between thiol from DTT to norbornene from NorHA). g) Elastic modulus of FN–HA hydrogels using different
concentrations of FN (XDTT 0.6). Graphs show mean ± SD (n = 3, measured twice); n.s, not statistically different via ANOVA.
(HA 0FN) showed minimal spreading, with diffuse actin stain-
ing and a rounded morphology (Figure 3a). MSCs spread well
and developed well-defined actin stress fibers on FN–HA hydro-
gels but no change in cell spreading was noted with increasing
amounts of FN incorporation, from 50 µg mL−1 FN up to 500
µg mL−1 (HA 50FN and HA 500FN, Figure 3a–d). This suggests
that the amount of adhesion domains available on the surface of
the material was already saturated at 50 µg mL−1 of FN and, as
the mechanical properties of the hydrogels are similar (≈7 kPa),
cells did not reflect any differences in morphology as quantified
by cell shape descriptors (i.e., total cell area, aspect ratio, round-
ness) (Figure 3b–d). To further investigate this, we performed a
vinculin staining to look at FA formation at early stages to see
whether increasing amounts of FN would result in larger FAs
(3 h) (Figure 3e–h). Interestingly, we only detected FAs in cells
seeded on HA 500FN, as can be seen by the number of FAs quan-
tified (Figure 3f), whereas vinculin staining was diffused and
mainly cytoplasmic in cells seeded on HA 50FN, even when cells
spread similarly on both HA 50FN and HA 500FN. The quantifi-
cation of both HA 0FN and HA 50FN suggests no FA formation
(Figure 3f–h) as cells still adhere and spread onto the surface of
HA 50FN hydrogels. This finding suggests the importance of the
role of HA in the initial cell adhesion, providing early cell attach-
ment on both HA 0FN and HA 50FN that is not integrin related.
As expected, FA formation does not occur in cells seeded on HA
0FN as HA has no receptors for integrins.
In order to study the role of HA in MSC attachment, we per-
formed early adhesion studies (3 h) to look at the cell-surface
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Figure 3. MSCs attach and spread onto FN–HA hydrogels. MSCs seeded on top of FNHA hydrogels with different amounts of FN (depicted as XFN
where X is the total amount of FN in micrograms per milliliter) for 3 h and assessed for spreading via a) imaging after staining for actin and nuclei
(scale bar: 200 µm, inset scale bar: 50 µm). Quantification of cell spreading was performed by measuring cell b) spread area (µm2), c) aspect ratio, and
d) roundness (mean ±SD, n > 100 cells, conditions in triplicate). Statistical differences determined with Kruskal–Wallis test followed by Dunn’s post
hoc test to correct for multiple comparisons where ****p < 0.0001. e) Representative images of FA formation after 3 h, nuclei (blue), actin (red), and
vinculin (green) (scale bar: 50 µm). Graphs (mean ± SD, n > 10 cells) showing the f) FA analysis with the number of FA per cell, g) the average FA area
per cell (µm2), and h) the average FA length per cell (µm).
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receptor CD44, which is one of the main proteins used by cells
to bind HA (Figure 4).[53,54] Cells seeded on top of HA 0FN hy-
drogels presented high signal for CD44 and form clusters (Fig-
ure 4a). Cells seeded on HA 50FN and HA 500FN also presented
CD44 staining, with less cluster formation and a more diffused
staining throughout the cytoplasm. This suggests that cells on
HA 0FN reorganize CD44. On hydrogels with FN, it is reason-
able to think that both CD44 and integrin binding are occurring
at the same time and so there could be less reorganization due
to competition between these two modes of attachment. On the
other hand, when MSCs were blocked for CD44 prior to seeding
(Figure 4b), we observed little to no attachment on HA 0FN hy-
drogels, with the few cells that remained on the gels presenting a
rounded morphology and a smaller cell area (Figure 4d). Differ-
ences were observed when comparing cell areas with and without
blocked CD44 (Figure 4c,d). On HA hydrogels without FN, cells
could not attach as shown by a dramatic drop in cell area mea-
surements. When comparing hydrogels with FN, cells were able
to attach and spread, but the overall cell areas decreased when
CD44 was blocked. More interestingly, cell areas decrease more
on HA 50FN compared to HA 500FN when CD44 is blocked.
This provides additional support to the role that HA has on early
MSC attachment. We also quantified CD44 cluster formation as
if they were FAs (Figure S1, Supporting Information; Figure 4e).
We found that cells seeded on HA 0FN developed bigger CD44
clusters compared to FN–HA hydrogels (as measured by cluster
area, Figure S1a, Supporting Information) and these differences
are even more noticeable when the areas of the CD44 clusters are
normalized by cell size (Figure 4e). This normalization is impor-
tant because cells on top of HA 0FN hydrogels are significantly
smaller compared to hydrogels with FN.
Yes-associated protein (YAP) has emerged as an important
marker of a cell response to local mechanical properties, act-
ing as a mechanical rheostat. YAP/TAZ are considered master
regulators of mechanotransduction, being of critical importance
in translating external mechanical signals (e.g., ECM stiffness)
to the nucleus and initiating downstream signaling through the
Hippo pathway.[55] Nuclear translocation of YAP has been shown
to depend not only on the stiffness of the material but also on
other parameters such as dimensionality and degradability.[4] Fig-
ure 5a shows the translocation of YAP for MSCs seeded on top
of HA FN hydrogels. For HA 0FN hydrogels (no FN)-only dif-
fuse, YAP staining was present in MSCs and mainly localized
in the cytoplasm, whereas cells seeded on top of hydrogels con-
taining FN (i.e., HA 50FN and HA 500FN hydrogels) presented
YAP staining in both the cytoplasm and, more notably, nucleus.
These events were further confirmed after quantification of the
YAP nuclear to cytoplasm (YAPnuc/cyt) ratio (Figure 5b), where a
trend was observed with the localization of YAP, correlating to
increasing amounts of FN in hydrogels, even though the elastic
modulus was similar across all formulations (XDTT 0.6, ≈7 kPa).
Classically, 2D substrates present a correlation between elevated
substrate stiffness and nuclear translocation of YAP,[55] where
cell spreading can regulate YAP/TAZ translocation to the nucleus
independent of the available adhesion area.[55]
Our data suggest that the amount of FN incorporated into HA
FN hydrogels plays a role in the nuclear translocation of YAP. For
example, Elosegui-Artola et al. reported that cell traction forces
decreased when cells were seeded on top of the substrates with
lower FN density (100 µg mL−1).[56] Cell traction forces are also
dependent on RGD spacing on hydrogels.[57] Thus, it may be ex-
pected that FN concentration would impact YAP in our system.
More fundamental studies have been performed using RGD
peptide tethering to investigate the relationship between ligand
density and cell behavior. Cell adhesion generally shows a sig-
moidal increase as a function of RGD concentration.[58] This
means that there is a critical minimum ligand density for cell
response. Massia and Hubbell found that cells need a minimum
of 1 fmol of RGD cm−2 for spreading and 10 fmol RGD cm−2 to
form FAs and stress fibers.[59] Similar results have been shown by
Rowley and Mooney using alginate-RGD gels.[60] Taken together,
the FN density readily available on the surface of the FN–HA
hydrogels could be an important asset for 2D adhesion studies.
Considering a hydrogel containing 50 µg mL−1 of FN (HA 50FN)
and considering also a homogeneous and isotropic distribution
of the protein through the first 10 nm of the hydrogel, the super-
ficial density of RGD of the hydrogel would be ≈200 fmol cm−2.
This is 20-fold more theoretical RGD compared to the minimum
needed to form FAs.[59] However, there are no FA formations on
these hydrogels but there are actin stress fibers. This suggests
that HA is also playing a critical role in early cell attachment and
that CD44 molecules interfere in the organization of FAs.
This hydrogel system could be used not only to study the effect
of FN concentration in 2D and 3D, but also, due to the presence
of full-length FN, we anticipate that the system could be loaded
with growth factors, which can bind to the heparin II binding do-
main on FN,[35] and thus be an invaluable platform to unveil the
relationship between growth factor signaling and mechanotrans-
duction in stem cell engineering.
2.5. MSCs in 3D FN–HA Hydrogels
After the initial characterization of this new hydrogel system, we
tested whether MSCs survive encapsulation. Figure 6a shows the
results for a Live/Dead staining at 3 days. MSC viability (Fig-
ure 6b) was equal or greater than 80%, which shows high cyto-
compatibility. As expected, this result confirms previous litera-
ture on the suitability of ultraviolet light-triggered thiol-ene reac-
tions for 3D cell culture as well as when FN is crosslinked.[4,22,61]
We also studied cell spreading and YAP translocation in 3D after
7 days (Figure 6c–f). Cell areas were bigger in cells seeded within
FN–HA hydrogels even though the aspect ratio was similar in
conditions with and without FN (Figure 6c,d). This shows that
cells are able to spread also in 3D using this system. No differ-
ences in cell area were found between HA 50FN and HA 500FN.
In addition, we looked at YAP translocation to the nucleus in 3D
(Figure 6e,f) and we did not find significant differences in the
signal of YAP between nucleus and cytoplasm, contrary to what
we found in 2D culture, where we detected an increase of YAP
translocation to the nucleus with increasing amounts of FN. YAP
nuclear translocation in HA hydrogels was previously reported
to be affected by dimensionality and, more specifically, by cell
spreading in 3D compared to 2D.[4] This could explain why we
observe similar levels of YAP nuclear translocation, as cell spread-
ing is similar among the three conditions tested (defined by the
aspect ratio) even when the average cell areas are bigger in FN–
HA hydrogels compared to HA only hydrogels. In this case, all
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Figure 4. Effect of HA in MSC attachment and spreading via CD44. MSCs were seeded on top of HA 0FN, HA 50FN, and HA 500FN hydrogels with and
without CD44 blocked, to study the effect of HA on cell attachment after 3 h. a) Representative images of cells where the nucleus is depicted in blue,
the actin cytoskeleton in red, and CD44 in green (scale bar: 50 µm). b) Representative images of MSCs with CD44 blocked prior to seeding on HA 0FN,
HA 50FN, and HA 500FN hydrogels for 3 h, nuclei (blue), actin (red) (scale bar: 50 µm). c) Cell areas for MSC adhesion after 3 h without blocking CD44
and d) cell areas for MSCs with CD44 blocked prior seeding on hydrogels for 3 h. (mean ± SD, n > 15 cells, except for HA 0FN with CD44 blocked as
there were not enough cells attached). ****p < 0.001, ***p < 0.005.
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Figure 5. Increased translocation of YAP into the nucleus with increasing amounts of FN on the same hydrogel stiffness (≈7 kPa, XDTT 0.6). MSCs
seeded on FN–HA hydrogels with different amounts of FN (depicted as XFN where X is the total amount of FN in micrograms per milliliter) for 3 h. a)
Representative images of cells (scale bar: 200 µm, inset: 50 µm), where red depicts actin, green YAP, and blue nuclei, respectively. b) YAP nuc/cyt ratio
as a function of the amount of FN used within the gels (0, 25, 50, or 500 µg mL−1). Data shown as mean ± SD (n ≥ 15 cells, conditions in triplicate)
with significant differences determined with ANOVA followed by Tukey’s post hoc test where *p < 0.5 and ***p < 0.005.
hydrogels were degradable, as they were crosslinked using the
protease-sensitive peptide. Future studies are needed to under-
stand the effects of both increasing degradability and increasing
amounts of FN in hydrogels of similar stiffness on YAP nuclear
translocation.
FN has been previously grafted onto a HA hydrogel for the 3D
culture of endothelial cells.[47,49] Photocrosslinnking via acrylate
groups was used to incorporate a previously PEGylated FN. FN
was incorporated up to 500 µg mL−1, whereas we prepared hy-
drogels with increasing amounts of FN and up to 2 mg mL−1.
Furthermore, they showed that the viability of endothelial cells
was around 40–50% except for the conditions with more FN in-
corporated that reached 90% viability. In our case, the viability
of HA 0FN (no FN) was as high as conditions with FN, showing
that the methodology of encapsulation is highly cytocompatible
and robust.[17] In summary, MSC viability after encapsulation via
thiol-ene UV-initiated photocrosslinking shows that this system
allows the in situ encapsulation of cells and cell spreading, prov-
ing its suitability as a 3D microenvironment too.[25]
3. Conclusions
We show a new approach to incorporate full-length FN into a nat-
ural HA hydrogel by synthesizing a norbornene-functionalized
HA and using it to directly and covalently bind FN during UV-
triggered thiol-ene crosslinking. These hydrogels were fabricated
to incorporate different amounts of FN. The mechanical proper-
ties were controlled independently of the amount of FN tethered
and MSCs respond to both HA and FN via CD44 and integrin
binding respectively. These hydrogels also supported 3D encap-
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Figure 6. MSCs encapsulated within FN–HA hydrogels show high viability. MSCs were encapsulated within FN–HA hydrogels incorporating either
nondegradable or degradable hydrogels and without and with FN (0FN and 50FN, 0 and 50 mg mL−1, respectively) for 3 days and their viability was
assessed by Live/Dead staining. a) Maximum Z-axis projection of a stack of images from the Live/Dead staining of different FN–HA hydrogels where
green and red represent live and red dead cells, respectively, for 3 days of culture (scale bar: 200 mm) and b) quantification of viability (mean ± SD, n = 3,
samples in triplicate) after 3 days of culture. c) Area (µm2) and d) aspect ratio of cells after 7 days in culture (mean ± SD, n > 10 cells). e) Quantification
of YAP nuclear translocation in 3D after 7 days of culture (mean ± SD, n > 10). f) Representative images of nucleus (blue), actin (red), and YAP (green)
staining (scale bar: 10 µm).
sulation and spreading of MSCs. This material is versatile system
that could be used as a platform for fundamental studies for stem
cell engineering, both in 2D and 3D.
4. Experimental Section
NorHA Synthesis: HA was first modified using tetrabutylam-
monium salt (HA-TBA). Briefly, sodium hyaluronate (Na-HA,
Lifecore Biomedical, ≈75 kDa) was dissolved in deionized (DI)
water at a concentration of 20 mg mL−1. Once dissolved, Dowex
resin (50WX8, Sigma) was added to the solution at a resin to Na-
HA ratio of 3:1 w/w for 2 h while stirring at room temperature.
Then, the mixture HA/resin was filtered using a Kitasato flask
(Whatman paper #2, vacuum). After that, a solution of TBA in DI
water was prepared (1:1 v/v). Neutralization of the HA solution
was performed using TBA solution, until pH 7.02–7.05. Once
neutral, the solution was partitioned into 50 mL tubes, frozen
(–80 °C, overnight), and lyophilized (4 days, <130E-03 mBar, –
80 °C). The product of lyophilization was stored at –20 °C until
use. 1H NMR spectrum of HA-TBA was performed dissolving
5 mg of HA-TBA in 700 µL of D2O; the spectrum obtained was
used to confirm the degree of modification.
NorHA was synthesized by mixing HA-TBA with 5-
norbornene-2-methylamine (Nor-amine) and anhydrous
dimethyl sulfoxide (DMSO, Sigma) (≈5 mL per 0.1 g HA-
TBA, via cannulation) in a round bottom flask under inert
atmosphere. Once HA was fully dissolved, a benzotriazole-1-
yl-oxy-tris-(dimethylamino)-phosphonium hexafluorophosphate
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Table 1. HA hydrogels formulations used. SH groups coming from the
crosslinker, either DTT (nondegradable) or protease-degradable peptide
(GCRDVPMSMRGGDRCG, degradable) were used.
HA hydrogels HA XFN
NorHA [mg mL−1] 20
FN [µg mL−1] X (0; 25; 50; 100; 500; 1000; 2000)
Ratio SH/Nor 0.6:1 (unless otherwise noticed)
(BOP, in DMSO) solution was added via cannulation to the
HA/Nor-amine solution and it was reacted for 2 h at room tem-
perature. After reaction, the solution was quenched with cold DI
water and transferred to a presoaked dialysis tube (MWCO 6–8
kDa). Dialysis was performed for 5 days in DI water (adding 5 g
NaCl in the dialysis water, changing water twice daily). Then, the
dialyzed product was filtered using a Kitasato flask (Whatman
paper #2, vacuum). The filtered product was dialyzed again in DI
water for 3–5 days. The dialyzed product was partitioned into 50
mL tubes, frozen overnight, and lyophilized for 4 days. 1H NMR
spectrum of NorHA was performed dissolving 5 mg of Nor-HA
in 700 µL of D2O; the spectrum obtained was used to confirm
the degree of modification.
HA Hydrogel Polymerization: Solutions containing NorHA
(2 wt%), DTT (Sigma), Irgacure 2959 (2-hydroxy-4′-(2-
hydroxyethoxy)-2-methylpropiophenone, Sigma, 0.05 wt%),
and Dulbecco’s phosphate-buffered saline (DPBS, Gibco) were
prepared using different formulations (Table 1). Once dissolved,
70 µL of the solution was placed on a polydimethylsiloxane
(PDMS) mold and the samples were covered with a glass cover-
slip. Then, samples were photopolymerized (Excelitas Omnicure
S1500, filter 320–390 nm, 10 min, 10 mW cm−2).
For FN–HA hydrogels, FN was denatured using 20 × 10−3
m tris(2-carboxyethyl)phosphine hydrochloride (TCEP) for 15
min. Then, the denatured FN was mixed with the HA solution
for 10 min and hydrogels were formed by photopolymerization
(10 min, 10 mW cm−2) using DTT or an in-house synthesized
protease-degradable peptide (GCRDVPMSMRGGDRCG) as
crosslinkers.
For cell encapsulation experiments, cells were resuspended in
HA polymer solution at a final density of 106 cells mL−1. The so-
lution with cells was added to a 6 mm cylindrical mold and irra-
diated for 10 min at 10 mW cm−2. The newly formed gels were
immediately transferred to a 24-well plate with a growth medium.
DMA Tests: Mechanical tests were performed using a DMA
Q800 (TA Instruments) in compression mode. F a force ramp of
0.5 N min−1 was applied up to 15 N of force were reached. The
compressive modulus (E) was obtained from stress–strain curves
and calculated as the slope between 10% and 20% strain using
TA Instruments software. Conditions were prepared in triplicate.
Each sample was measured twice.
Cell Adhesion Assay on NorHA Hydrogels: For cell adhesion
experiments, human primary MSCs (from bone marrow, Promo-
Cell) were grown in 10 mm petri dishes using growth medium
(𝛼-Modified Eagle’s Medium (𝛼-MEM) and 10% fetal bovine serum
(FBS, Gibco)). All hydrogels were polymerized and maintained
in DPBS until seeding. Cells were seeded on top of the hydro-
gels at a density of 5000 cells cm−2 for 3 h in medium without
serum. Glass controls were seeded at the same cell density using
growth medium. Cells were fixed using 4% paraformaldehyde for
30 min at room temperature. Samples were washed twice with
DPBS after fixation and kept at 4 °C until immunostaining was
performed.
CD44-blocking experiments were performed incubating
MSCs with mouse-anti-CD44 (dilution 3:1000 in 2% FBS/DPBS
v/v buffer)[53,62] for 45 min on ice. Cells were washed twice in 2%
FBS/DPBS and resuspended in growth media without serum
for seeding.
Cell Viability: Cytocompatibility of hydrogels with MSCs was
tested using Live/Dead assay (Thermo Fisher) following man-
ufacturer’s instructions. Briefly, samples were washed twice in
DPBS and then immersed in 2 × 10−3 m calcein-AM and 4 × 10−3
m ethidium homodimer-1 and incubated for 15 min. Then, sam-
ples were washed twice with DPBS and imaged using a confocal
microscope (Leica) at 10× and 20× magnification.
Immunostaining: FN was detected via immunostaining in hy-
drogel samples. Hydrogels were blocked with blocking buffer
(1% bovine seroalbumin (BSA) in DPBS) for 30 min at room
temperature. Then, primary antibody rabbit polyclonal-anti-FN
(Sigma) was added and incubated for 1 h at room temperature.
After the addition of the primary antibody, samples were washed
three times using washing buffer (0.5% Tween 20 in DPBS).
Then, secondary antibody goat-anti-rabbit-Cy3 was incubated for
1 h at room temperature (protected from light). After that, sam-
ples were washed three times using washing buffer. Images were
taken using a confocal microscope (Leica).
Immunostaining to detect YAP was performed as follows.
First, cells were permeabilized with 0.1% Triton X-100 (Sigma)
for 5 min and blocked with 3% BSA for 45 min. After block-
ing, the primary antibody rabbit-anti-YAP was added and in-
cubated overnight at 4 °C (Santa Cruz Biotechnology, dilution
1:200). Then, the primary antibody was washed thrice with wash-
ing buffer. After washing, a secondary antibody goat-anti-rabbit-
Alexa Fluor 488 was added for 2 h at room temperature (Thermo
Fisher, dilution 1:200). Three washes with washing buffer follow
the antibody incubation. Then, rhodamine phalloidin was added
for 20 min (Thermo Fisher, dilution 1:200) and 4ʹ,6-diamidino-
2-fenilindol (Thermo Fisher, DAPI) staining for 10 min (dilu-
tion 1:5000). Images were taken using an epifluorescence micro-
scope (Nikon) at 20× magnification. For 3D experiments, hydro-
gels were mounted using VECTASHIELD (Vector Laboratories)
mounting medium on bottom glass petri dishes and images were
taken using an epifluorescence microscope (ZEISS) at 20× and
40× magnification.
Immunostaining to detect vinculin/CD44 was performed as
follows. First, cells were permeabilized with 0.1% Triton X-100
(Sigma) for 5 min and blocked with 1% BSA for 30 min. Af-
ter blocking, the primary antibody mouse-anti-vinculin (Sigma,
dilution 1:400)/mouse-anti-CD44 (Abcam, dilution 1:200) was
added and incubated for 1 h at room temperature. Then, the
primary antibody was washed thrice with washing buffer. After
washing, a secondary antibody rabbit-anti-mouse-Cy3 was added
for 1 h at room temperature (Jackson ImmunoResearch, dilu-
tion 1:200) together with 488-phalloidin (Thermo Fisher, dilu-
tion 1:200). Then, samples were washed five times with washing
buffer and mounted using VECTASHIELD with DAPI (Vector
Laboratories).
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Image Analysis—Cell Morphology Analysis: Cell shape descrip-
tors were measured using ImageJ 1.51v (National Institutes of
Health, USA). Briefly, actin cytoskeleton images were binarized
using a threshold function. Then, the wand tracing tool was used
to select the outline of the cell and the measure function was used
to calculate parameters such as cell area, aspect ratio, and round-
ness. The aspect ratio is defined as the ratio between the major
and minor axis of the shape selected and the roundness was cal-
culated as follows:
Equation (1): Roundness calculation






Image Analysis—Viability from Live/Dead Staining: The per-
centage of the viability was calculated from the stack of images
taken using ImageJ. For each channel, the maximum intensity
Z-projection images were obtained using ImageJ. Then, a Gaus-
sian blur filter was passed (sigma ball radius of 2) and the number
of cells in each channel was counted using the find maxima pro-
cess tool (ImageJ). The total number of cells was calculated using
Equation (2) and the percentage of cell viability was calculated as
per Equation (3).
Equation (2): Calculation of the total number of cells for
Live/Dead staining
Ntotal = livecells + deadcells
where livecells is the total number of cells quantified using the live
channel stack and deadcells is the total number of cells quantified
using the dead channel.







Image Analysis—YAP Localization: For YAP localization ex-
periments, MSCs were grown in 10 mm petri dishes using
growth medium. All hydrogels were polymerized and main-
tained in DPBS until seeding. Cells were seeded on top of the
hydrogels at a density of 5000 cells cm−2 for 3 h in medium with-
out serum.
The quantification of YAP was assessed from the fluorescence
images using ImageJ. The nuclear/cytoplasm ratio was calcu-
lated using Equation (4).










where YAPnuc is the integrated density of YAP in the nucleus,
Anuc is the area of the nucleus, YAPcyt is the integrated density of
YAP in the cytoplasm (Equation (5)), and Acyt is the area of the
cell cytoplasm (Equation (6)).
Equation (5): YAP’s integrated density fluorescence in the cy-
toplasm
YAPcyt = YAPcell − YAPnuc
where YAPcell is the integrated density of YAP in the entire cell.
Equation (6): Definition of cytoplasmic area
Acyt = Acell − Anuc
where Acell is the area of the entire cell.
Image Analysis—Vinculin and CD44 Analysis: Vinculin im-
ages were used for FA quantification following a step-by-step
method developed by Horzum et al.[63] and implementing it in
ImageJ. CD44 images were analyzed using the FA analysis server
using a threshold of 2 and the actin images as a cell mask.[64]
FN Release: FN was fluorescently labeled using the DyLight-
488-NHS Ester kit (Thermo Fisher) following manufacturer’s in-
structions. Briefly, FN was dialyzed against 0.5 m borate buffer
(pH 8) and then mixed for 1 h at room temperature with the
fluorophore. After that, the labeled protein was dialyzed again
to phosphate buffer (DPBS) and kept frozen until use. Hydro-
gels were fabricated without FN, with FN treated with TCEP
(crosslinked), or with FN without TCEP (physically trapped). Hy-
drogels were immersed in DPBS and kept at room temperature.
DPBS was removed every day to measure fluorescence. Fluores-
cence was measured using a plate reader (Tecan) together with
a standard curve made with the same labeled FN. Samples were
fabricated in triplicate.
Statistical Analysis: The statistical analysis was performed us-
ing GraphPad Prism 6.01 software. All experiments were carried
out in triplicate. All graphs represent mean ± standard devia-
tion (SD). The goodness of fit of all datasets was assessed via
D’Agostino–Pearson normality test. For comparisons of three or
more groups: normally distributed populations were analyzed via
analysis of variance (ANOVA) with a Tukey’s post hoc test to cor-
rect for multiple comparisons; for populations not distributed
normally, a Kruskal–Wallis test was used with a Dunn’s post
hoc test to correct for multiple comparisons. Differences among
groups are stated as p < 0.05 (*), p < 0.01 (**), p < 0.005 (***), p
< 0.001 (****) when differences between groups are not statisti-
cally significant (n.s.).
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